(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)

Metabolite details

Identifier

USYNZBLVOOXNSN-ARRWHRBTSA-N

InChI Key

USYNZBLVOOXNSN-ARRWHRBTSA-N

IUPAC name

(2S,3S,4S,5R)-6-[(4S,6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-hydroxy-2-methyl-3-oxoheptan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

Preferred name

(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)

INN name

—

Synonym

—

ChEBI

CHEBI:180774

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)

Observed in differential profiles

• Wild_type_vs_hfq
• 2:00 AM_Membrane_vs_2:00 AM_Net
• G1_PBS_vs_G2_DSS
• Sham_vs_Radiofrequency
• Normal_vs_Neural_Tube_Defect